Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT00721058
Eligibility Criteria:
Inclusion Criteria:
* Eligible for breast conserving therapy i.e. histologically proven breast cancer
* Operable disease
* Visible mass on mammography or ultrasound \> 0.5 c
Exclusion Criteria:
* All contra-indications for breast conserving therapy, i.e. previous radiotherapy of the breast, multicentricity, inoperable disease, or too large tumor in a relatively too small breast, pregnancy.
* Contra-indications for intravenous contrast, i.e. iodine allergy, renal malfunction (kreatinine clearance \< 60 ml/min), , previous allergic reaction to i.v. contrast, M. Kahler, use of NSAIDs, Diuretics or Metformine.
* Absence of tumor mass \> 0.5 cm on conventional mammography or ultrasound
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00721058
Study Brief:
Protocol Section:
NCT00721058